Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,063 | -25,388 | -12,080 | -50,500 | -38,937 |
| Depreciation Amortization | 6,525 | 4,334 | 2,157 | 7,884 | 5,896 |
| Accounts receivable | 993 | 4,720 | 2,355 | -878 | 797 |
| Accounts payable and accrued liabilities | 345 | -1,143 | -1,043 | -1,389 | -3,408 |
| Other Working Capital | -5,794 | -1,341 | -1,420 | -3,057 | -5,777 |
| Other Operating Activity | 9,423 | 3,202 | 1,850 | 15,428 | 12,529 |
| Operating Cash Flow | $-25,571 | $-15,616 | $-8,181 | $-32,512 | $-28,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 145 | -8,640 | -4,214 | 36,522 | 27,715 |
| PPE Investments | -1,193 | -467 | -333 | -2,575 | -1,060 |
| Investing Cash Flow | $-1,048 | $-9,107 | $-4,547 | $33,947 | $26,655 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 50,000 | 50,000 | 50,000 | 7,098 | 0 |
| Debt Repayment | -35,070 | -35,140 | -35,116 | -92 | -68 |
| Common Stock Issued | 3,269 | 896 | 430 | 1,083 | 557 |
| Other Financing Activity | -3,588 | -3,588 | -3,588 | -20 | -20 |
| Financing Cash Flow | $14,611 | $12,168 | $11,726 | $8,069 | $469 |
| Exchange Rate Effect | 30 | 2 | 20 | 28 | 27 |
| Beginning Cash Position | 37,044 | 37,044 | 37,044 | 27,512 | 27,512 |
| End Cash Position | 25,066 | 24,491 | 36,062 | 37,044 | 25,763 |
| Net Cash Flow | $-11,978 | $-12,553 | $-982 | $9,532 | $-1,749 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,571 | -15,616 | -8,181 | -32,512 | -28,900 |
| Capital Expenditure | -1,193 | -467 | -333 | -2,575 | -1,060 |
| Free Cash Flow | -26,764 | -16,083 | -8,514 | -35,087 | -29,960 |